A detailed history of Nations Financial Group Inc, transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Nations Financial Group Inc, holds 11,226 shares of COLL stock, worth $331,054. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,226
Previous 10,012 12.13%
Holding current value
$331,054
Previous $322,000 34.47%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$31.4 - $39.07 $38,119 - $47,430
1,214 Added 12.13%
11,226 $433,000
Q2 2024

Jul 29, 2024

BUY
$31.36 - $39.99 $2,383 - $3,039
76 Added 0.76%
10,012 $322,000
Q1 2024

Apr 23, 2024

BUY
$31.23 - $40.91 $310,301 - $406,481
9,936 New
9,936 $385,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.01B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.